← boothcheck

EHC vs THC stock comparison

Encompass Health Corporation vs TENET HEALTHCARE CORP, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Neither multiple is about growth so much as persistence: Tenet at 9.8 times earnings is priced for hospital margins to fade from their post-pandemic highs, Encompass at 16.9 for rehabilitation demand to compound as demographics promise. Tenet's current numbers dominate, a 24.1% operating margin, a 39.5% return on equity (geared, 1.97 turns), and a 20.4% free-cash yield that dwarfs Encompass' construction-negative flow. Encompass answers with cleaner leverage, 0.78 turns, and a structural story no cycle owns. Seven turns of multiple separate earnings the market distrusts from earnings it believes in; Tenet's page pays you enormously to share the distrust.

Comparison updated 2026-07-10.

EHC vs THC: the numbers

MetricEHCTHC
Price$101.30$187.50
Market cap$10.2B$16.4B
SectorMedical CareMedical Care
StageMatureMature
Implied growth (priced in)+8.8%
P/E16.99.8
P/B3.082.45
P/S1.680.77
EV/EBITDA37.75.6
Revenue growth+10.1%+4.5%
Operating margin24.1%
Net margin10.0%12.4%
Return on equity18.4%39.5%
Return on assets8.3%8.5%
Return on invested capital15.5%
FCF yield-7.2%20.4%
Dividend yield0.7%
Debt / equity0.781.97
Current ratio1.171.36
Altman Z (solvency)2.401.58
Piotroski F (quality)5 / 97 / 9
Full EHC report → Full THC report →
Get boothcheck's read on EHC and THC, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.